Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2299024Generated: November 2, 2026

Benzimidazole → N-[(5S)-3-(3-Fluoro-4-(4-benzimidazol-1-ylmethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-ylmethyl]acetamide

https://huagongshe.com/reaction/2299024

Reaction equation

Participants

RoleNameHCIDCharge
ReactantBenzimidazoleHCID 5798—
Reactant1,1-Bis(2,2-dimethylpropoxy)-N,N-dimethylmethanamineHCID 78623—
ReactantN-[(5S)-3-(3-Fluoro-4-(4-hydroxymethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-yl-methyl]acetamideHCID 10760118—
SolventAcetonitrileHCID 6342—
ProductN-[(5S)-3-(3-Fluoro-4-(4-benzimidazol-1-ylmethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-ylmethyl]acetamideHCID 7015351337.3%

Reaction Steps

N-[(5S)-3-(3-Fluoro-4-(4-hydroxymethylimidazol-1-yl)phenyl)-2-oxooxazolidin-5-yl-methyl]acetamide (104 mg, 0.3 mM) and benzimidazole (71 mg, 0.6 mM) were suspended in dry acetonitrile (6 ml) under argon, and NAN-dimethylformamide dineopentyl acetal (208 mg, 0.9 mM) added. The mixture was refluxed for 8 hours. Solvent was evaporated, and the residue dissolved in dichloromethane and chrornatographed on a 10 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 20% methanol in dichnoromethane. Relevant fractions were combined and evaporated to give the title product (50 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06495551B1
Source datasetuspto-grants-2002_12
ORD IDord-f88d095bb2c04c7eacfa54f5a29922b2
Source noteuspto-grants-2002_12